Clinical Trial Update: A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial comparing acetaminophen extended-release with rofecoxib for osteoarthritis of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Acetaminophen Extended-Release (acetaminophen)
• Rofecoxib (rofecoxib)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED